Země: Velká Británie
Jazyk: angličtina
Zdroj: MHRA (Medicines & Healthcare Products Regulatory Agency)
Cilastatin sodium; Imipenem monohydrate
Kent Pharma (UK) Ltd
J01DH51
Cilastatin sodium; Imipenem monohydrate
500mg ; 500mg
Powder for solution for infusion
Intravenous
No Controlled Drug Status
Valid as a prescribable product
BNF: 05010202